Background Tuberculosis (TB) infection is highly prevalent in
Medan, TB was suspected to be 264 per 100,000 people, with a positive pulmonary TB proportion of 10.3%, according to Tuberculous Sub-Directorate of Indonesian Ministry of Health (Subdit TB Depkes RI) 2000-2010. 7 In Indonesia, the Bacille Calmette-Guerin (BCG) vaccination has been used for TB prevention, but its efficacy is still debated. 3 The protective effect of the BCG vaccine was found to be between 0 and 80%, in clinical and case-control studies carried out in various countries. 8 Persons living in the household of a TB patient have a high risk of becoming infected, so it is important to evaluate children in these homes. The Mantoux test is the standard method to detect TB infection. BCG vaccination can affect Mantoux test results until 5 years after immunization. 3 The aim of this study was to assess for an association between Mantoux test results and BCG vaccination in children who had contact with adult pulmonary tuberculosis and to assess for differences in Mantoux test indurations associated with nutritional status, age, type of TB contact, and duration since BCG vaccination, in both BCG-vaccinated and BCGunvaccinated children.
Methods
A cross-sectional study was undertaken on household contacts of adult pulmonary TB patients with positive sputum smears who registered at the pulmonary specialist outpatient center and Balai Pengobatan Pemberantasan Penyakit Paru paru (BP4) in Medan. Children aged 3 months to 5 years who lived with adult pulmonary TB patients with positive sputum smears and whose parents approved and were willing to fill out questionnaires were included in the study.
We excluded children with severe malnutrition, measles, mumps, severe tuberculosis, abdominal typhoid, malignancy, those in an immunocompromised state, likely to receive long-term corticosteroid therapy or other immunosuppressive drugs, as well as those with other conditions that affect immune status. In addition, children who received a live vaccine immunization in the 6 weeks prior to the study or a Mantoux test in the 2 weeks prior to the study were excluded from the study. We divided the participants into two groups: BCG-vaccinated and BCG-unvaccinated.
Immunization status information was obtained from parents, observation of BCG scars in deltoid area or their Kartu Menuju Sehat registration.
The minimum required sample size was calculated using a formula to test the hypothesis of two independent proportions resulting in 50 children per group. Subjects' baseline characteristics and information were obtained from questionnaires completed by parents. Mantoux tests were performed on all subjects using PPD RT 23 2TU at a dose volume of 0. 
Results
Characteristics and distribution of subjects in both groups are shown in Table 1 . Mean age, gender, weight, and height were similar in the BCG-vaccinated and BCG-unvaccinated groups. The most common maternal and paternal educational levels were senior high school for both groups.
The mean diameters of Mantoux test induration in the BCG-vaccinated and unvaccinated groups were not significantly different ( Table 2) . However, we found that significantly more BCG-vaccinated subjects had negative Mantoux test results than Linear regression analysis revealed no significant relationship between duration since BCG vaccination and Mantoux test induration (r=0.03), as shown in Figure 1 .
Discussion
The aim of our study was to analyze the status of BCG immunization as a protective factor for TB infection, unvaccinated subjects with odds ratio (OR) 0.113, indicating that BCG immunization was a protective factor against TB infection ( Table 3) .
Anova test revealed no significant differences in diameters of Mantoux test induration between groups, with regards to age and nutritional status (P>0.05) ( Table 4) . Table 5 shows there were no significant differences in Mantoux test induration between groups, based on history of TB contact. Table 1   Table 3   Table 2 where Mantoux test were used to determine the status of TB infection. In this study, all the subjects had been exposed to adults in their household with TB-positive sputum smears. Baseline characteristics of subjects were similar in the two groups.
Tuberculosis remains the most frequentlyoccurring, infectious disease in the world, and the WHO estimates that the incidence will continue to increase. 9, 10 The important risk factors for transmission of infection are young age, an immunocompromised state, and contact with an adult who has TB-positive sputum. 11, 12 Additional factors are associated with physical characteristics of the household, e.g, size, crowding, and ventilation. 11, 13 A study in Greenland, Denmark found that low maternal education level was associated with higher risk of TB infection among children, but no relationship with paternal educational level was reported. 14 We did not assess for this association, but we found that maternal educational level was higher in the BCG-vaccinated group than in the BCGunvaccinated group.
The cellular immune response is responsible for protection against TB infection. 3, 15 The tuberculin test is a diagnostic tool with high sensitivity and specificity for detecting TB infection. 16 Figure 1 identify children in a BCG-vaccinated population who had recent exposure to persons with pulmonary TB, and were probably infected with M. tuberculosis. 20 We considered the Mantoux test to be positive for subjects. A study in Hamburg, Germany compared a Mycobacterium tuberculosis-specific enzyme-linked immunospot (ELISPOT) assay to the tuberculin test. They found that for occasional and BCG-vaccinated contact, the tuberculin skin test cut-off point should be raised from 5 to 10 mm in order to minimize the number of false positive results. 21 A study in Canada showed that Mantoux test induration cut-off point of 15 mm was able to eliminate the false positive BCG effect. 22 We found no statistically significant difference in mean tuberculin skin test induration in the BCG-vaccinated and BCG-unvaccinated groups. An Istanbul study reported that the tuberculin test induration diameter in BCG-vaccinated subjects was significantly higher than in BCG-unvaccinated subjects. 6 These children stayed in the same house with adult TB pulmonary patients, hence, their daily exposure to M. tuberculosis increased their cellular immune response. This cellular immune response was greater than that from BCG vaccination. 6 We found positive Mantoux test results in 18% of the vaccinated and 66% of the unvaccinated groups, while negative test results were 82% and 34%, respectively ( Table 3) . In an Umerkot, Pakistan study, positive Mantoux test results in the vaccinated and unvaccinated groups were 19% and 81%, respectively, and negative results were 11.7% and 88.3%, respectively. 23 These variations may have been due to different vaccine strains, doses, methods and routes of vaccine administration, subjects' age and nutritional status, virulence of prevealent TB strains, and atypical mycobacterial prevalence. 3 We also used different cut-off points for Mantoux test induration diameters for the BCG-vaccinated and BCG-unvaccinated children. So far, more than 3 million BCG vaccine doses have been used worldwide, but use of the vaccine remains controversial and uncertain. 3 The BCG vaccine can affect Mantoux test results, causing false positive results. This effect declines over time, and should be minimal 5 years after receiving the vaccine. 3, 24 A systematic review performed in Brazil reported that the BCG vaccine has a high protective effect against clinical forms of meningeal and miliary tuberculosis, but its protective effect against pulmonary TB varies widely. 8 These variations have been attributed to different factors, including differences in exposure to mycobacteria in the environment, genetic characteristics of a population, the virulence of the M. tuberculosis strains, the strains comprising the BCG vaccines, and nutritional differences in those undergoing vaccinations. 24 We also found a significant association between negative Mantoux test receiving BCG vaccination (P=0.0001; OR=0.113). Similary, a Turkish study reported that in children exposed to adult TB patients, the ELISpot and Mantoux tests showed that BCG-vaccinated children had an OR of 0.60 for TB infection compared to unvaccinated children. 25 A study in India also found that BCG-unvaccinated children had higher risk for TB infection. 12 We found no significant differences in Mantoux test indurations between the groups, with regards to age and nutritional status, in contrast to an Indian study. 12 This difference may have been due to the lack of malnutritioned children in our study, although the mean ages were similar.
In our study, we found no association between the duration since BCG vaccination and Mantoux test induration, similar to a Turkish study with no significant differences in Mantoux test induration in the groups of children until 6 years of age. 6 In contrast, a study in Iran showed that Mantoux test induration decreased with age, therefore, it may be necessary to repeat BCG vaccination in children at the age of entering primary school. 26 The strength of our study was that all subjects had similar characteristics, and the factors that influenced Mantoux test results were comparable between groups. Limitations of this study were that the positive Mantoux test results could not be attributed only to M. tuberculosis infection and that the duration after immunization was not the same for all children. Further research is needed to assess the relationship of BCG immunization status with Mantoux test.
